8 Hub & Spoke Nodes
94.5% Cohort Retention (Target 85-96%)
5.1 wks Ethics Turnaround (Target ≤ 6w)
72 hrs Pandemic Surge Activation
0 Major GCP Violations

Pan-African Clinical Research Network (Hub & Spoke Architecture)

Connecting centralized academic tertiary research hospitals to community health center spokes where patients receive primary care.

Selected Node Architecture

Select a site to inspect capability

Click any clinical site node on the left to review investigator capacity, cold-chain readiness, biobanking specs, and linked spoke clinics.

RFP Feasibility & Protocol Matching Engine

Rapid turnaround feasibility assessment for international pharmaceutical sponsors and CRO development partners.

Protocol Requirements (Sponsor Input)

Feasibility Evaluation Output

Configure protocol parameters and click generate to assess network capacity and enrollment velocity.

Offline-First eSource & Mobile Clinic Encounter Simulator

Built for primary clinic coordinators operating in rural and intermittent connectivity environments. 21 CFR Part 11 ALCOA+ audit compliant.

Spoke Clinic Patient Encounter Entry

Online Queue

Verified eSource Log (Audit Trail)

SHA-256 Verified

Participant Engagement, Multilingual Nudges & Automated Stipends

Driving EzCRO's industry-leading 85–96% retention rate with cultural engagement and instant mobile money reimbursements.

Automated Multilingual Protocol Nudges

WhatsApp / SMS Gateway

Instant Participant Transport Stipend Disbursals

Ozow / Mobile Money Integration
R 486,250 Total Disbursed MTD
100% Ethics Reconciled

Transport stipends are automatically triggered upon nurse check-in at primary care spoke clinics, eliminating cash handling risks on site.

Participant SOW-1042 · Chiawelo Clinic
+R 350.00 (Instant EFT)
Participant KHA-2099 · Khayelitsha CHC
+R 400.00 (Mobile Money)
Participant UML-3011 · Umlazi Clinic
+R 350.00 (Instant EFT)

Sentinel Outbreak & Pandemic Preparedness Surveillance Console

Powers EzCRO's Service 03. Standing research infrastructure capable of 72-hour trial surge activation for emerging pathogens.

Pandemic Response State

STANDING SURVEILLANCE & EARLY SIGNAL DETECT

When an outbreak signal exceeds baseline thresholds, EzCRO’s standing ethics frameworks, cold-chain pipelines, and pre-trained investigator network can activate Phase I-IV vaccine and therapeutic trials in 72 hours.

Sentinel Primary Care Node Surveillance Feed

Real-time Syndromic Feed
Node & Site Syndromic Indicator Weekly Volume Baseline Deviation Signal Status Last Update

Regulatory Compliance & Inspection-Ready eTMF

Continuous alignment with SAHPRA (South Africa), African Medicines Agency (AMA), ICH-GCP E6(R2/R3), and FDA 21 CFR Part 11.

SAHPRA Milestone Tracker

  • Protocol Submission Completed Day 0
  • Ethics Review (NHREC Accredited) Approved (Week 4.8)
  • IMP Import Permit Verification Under Review (ETA 3 Days)
  • First Patient In (FPI) Target Target: ≤ 7 Days post-clearance

ALCOA+ Data Integrity Standard

  • Attributable: Cryptographic digital sign-offs by GCP staff.
  • Legible: Native digital source records, zero transcription loss.
  • Contemporaneous: Real-time timestamping at patient visit.
  • Original: Primary digital capture at spoke nodes.
  • Accurate: Automated sanity limits on vitals and eligibility.

Africa Clinical Trials Advantage

1.4 Billion World's most genetically diverse patient pool
4% → 15% EzCRO's mission to expand Africa's trial share
Zero Major GCP audit non-conformances